BetterScholar BetterScholar

V. Pathak

Clinical Medicine Insights: Endocrinology and Diabetes, Diabetes, Journal of Endocrinology, Peptides, Molecular and Cellular Endocrinology, Stem Cells Translational Medicine, Diabetologia, Biochemical Pharmacology Show more
8
Role
Title
Level Year L/R
🦁 Therapies for Type 1 Diabetes: Current Scenario and Future Perspectives
V. Pathak, N. Pathak, C. O’Neill, Jasenka Guduric-Fuchs, R. Medina 		6 2019
6
🦁
🐬 A Novel CCK-8/GLP-1 Hybrid Peptide Exhibiting Prominent Insulinotropic, Glucose-Lowering, and Satiety Actions With Significant Therapeutic Potential in High-Fat–Fed Mice
N. Irwin, V. Pathak, P. Flatt 		6 2015
6
🐬
🐜 Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice.
9 auth. Paul Millar, N. Pathak, V. Parthsarathy, A. Bjourson, M. O’Kane, V. Pathak, ... R. Moffett, P. Flatt, V. Gault 		6 2017
6
🐜
🦁 Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes
V. Pathak, P. Flatt, N. Irwin 		5 2018
5
🦁
🦁 Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice
V. Pathak, V. Gault, P. Flatt, N. Irwin 		5 2015
5
🦁
🐜 Current concepts on endothelial stem cells definition, location, and markers
9 auth. Sarah E. J. Chambers, V. Pathak, E. Pedrini, Lou Soret, N. Gendron, C. Guerin, ... Alan W. Stitt, D. Smadja, R. Medina 		5 2021
5
🐜
🦁 Sequential induction of beta cell rest and stimulation using stable GIP inhibitor and GLP-1 mimetic peptides improves metabolic control in C57BL/KsJ db/db mice
V. Pathak, S. Vasu, V. Gault, P. Flatt, N. Irwin 		5 2015
5
🦁
🐬 Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential
N. Pathak, V. Pathak, V. Gault, S. McClean, N. Irwin, P. Flatt 		5 2018
5
🐬